Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

14 avr. 2026 10h59 HE | Source: Research and Markets

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Drug Development Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The drug development services market has...
14 avr. 2026 03h26 HE | Source: Mordor Intelligence

Cell Line Development Market to Reach $8.95 Bn by 2031 with Gene & Cell Therapy Manufacturing Growing at 10.88% CAGR, Says Mordor Intelligence

Cell line development market driven by biologics, mAbs and gene therapies, with innovation and automation led by Thermo Fisher, Merck, Danaher, Lonza.
02 avr. 2026 08h07 HE | Source: Curanex Pharmaceuticals Inc

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX)...
01 avr. 2026 13h47 HE | Source: BCC Research LLC

Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand

Increasing adoption of cloud platforms is enabling scalable data analysis, accelerating genomics research, and streamlining drug development workflows.
30 mars 2026 11h12 HE | Source: Mordor Intelligence

AI in Drug Discovery Market to Hit USD 10.29 Bn by 2031 with Quantum Machine Learning Advancing Rapidly at 27%+ CAGR - Mordor Intelligence Report

Hyderabad, India, March 30, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the artificial intelligence in drug discovery market size was valued at USD 2.58 billion in 2025 and is...
30 mars 2026 02h00 HE | Source: Draupnir Bio

Draupnir Bio announces transformational publication detailing extracellular targeted protein degradation technology in Cell Chemical Biology

Draupnir’s novel SORTAC platform expands reach of targeted protein degradation to extracellular proteins, demonstrating in vitro and in vivo efficacy against difficult-to-drug targetsStudy further...
23 mars 2026 11h46 HE | Source: ProductLife Group (PLG)

Dr. James Burt Joins ProductLife Group as CEO

ProductLife Group appoints Dr. James Burt as CEO, strengthening global growth and capabilities across regulatory, clinical, quality and digital services.
23 mars 2026 10h05 HE | Source: AdipoPharma

AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass

PITTSBURGH, March 23, 2026 (GLOBE NEWSWIRE) -- As GLP-1 therapies reshape obesity care, one biotech company is betting that the root cause of Type 2 diabetes isn’t only excessive weight but a...
23 mars 2026 03h00 HE | Source: Draupnir Bio

Groundbreaking Danish research project launches to cure Parkinson’s disease

A new research project aims to develop the world’s first therapy to eliminate and prevent the spread of a toxic brain protein that drives Parkinson’s disease. Innovation Fund Denmark has invested DKK...
17 mars 2026 06h30 HE | Source: Avance Clinical

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Avance Clinical Appoints Liahna Toy to Lead Global Early Phase Center of Excellence, Advancing Accelerated Early Phase Delivery for Biotechs

Page suivante